{"database": "lobbying", "table": "lobbying_activities", "rows": [[127630, "8d199abc-b2fd-4ba6-ab6c-60452c1cfdce", "YY", "ZUCKERMAN SPAEDER LLP", 42160, "ANDRX PHARMACEUTICALS INC", 2001, "year_end", "MED", "Food & Drug Administration authorization of generic version of Tiazac and Prilosec; policy issues concerning generic drugs.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2002-02-04T00:00:00-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["127630"], "units": {}, "query_ms": 61.99768395163119, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}